Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30754357 | 1.00 | CES2 (0.36) | CES2CES1ALDH1A1MEN1KMT2A | |
| SCHEMBL621701 | 1.00 | CES2 (0.36) | CES2CES1ALDH1A1MEN1KMT2A | |
| SCHEMBL29238077 | 0.85 | CES2 (0.42) | CES2CES1ALDH1A1MEN1KMT2A | |
| SCHEMBL1137681 | 0.85 | — | — | |
| SCHEMBL14789351 | 0.85 | — | — | |
| SCHEMBL12216938 | 0.85 | — | — | |
| SCHEMBL23113665 | 0.81 | ABAT (0.39) | CES2CES1ALDH1A1MEN1KMT2A | |
| SCHEMBL22975387 | 0.81 | ABAT (0.39) | CES2CES1ALDH1A1MEN1KMT2A | |
| SCHEMBL3598427 | 0.79 | CES2 (0.41) | CES2CES1ALDH1A1MEN1KMT2A | |
| SCHEMBL3598429 | 0.79 | CES2 (0.41) | CES2CES1ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4676880-B2 | — | — | 2011-04-27 | — | — | JP | claimed |
| US-7888309-B2 | 1-Alkanoyl-substituted cyclooctenes having agrestic, natural, and floral, green, woody odor notes; preferably, 1-cyclooct-3-enylethanone, 1-cyclooct-3-enylpropan-1-one, 1-cyclooct-3-enyl-2-methylpropan-1-one; cleaning compounds; personal care; cosmetics; detergents; fabric softeners; shampoos; gels etc. | GIVAUDAN SA (CH) | 2011-02-15 | — | — | US | claimed |
| US-20090325836-A1 | Cyclooct-(EN-)YL Derivatives for Use as Fragrances | GIVAUDAN SA (CH) | 2009-12-31 | — | — | US | claimed |
| EP-1555998-B1 | CYCLOOCT-(EN-)YL DERIVATIVES FOR USE AS FRAGRANCES | GIVAUDAN SA (CH) | 2009-07-29 | — | — | EP | claimed |
| JP-2006512470-A | — | — | 2006-04-13 | — | — | JP | claimed |
| US-20060014663-A1 | Cyclooct-(en-)yl derivatives for use as fragrances | GIVAUDAN SA (CH) | 2006-01-19 | — | — | US | claimed |
| EP-1555998-A1 | CYCLOOCT-(EN-)YL DERIVATIVES FOR USE AS FRAGRANCES | Givaudan SA (CH) | 2005-07-27 | — | — | EP | claimed |
| WO-2004035017-A1 | CYCLOOCT-(EN-)YL DERIVATIVES FOR USE AS FRAGRANCES | GIVAUDAN SA (CH) | 2004-04-29 | — | — | WO | claimed |
| US-20250235136-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-07-24 | — | — | US | disclosed |
| US-12336820-B2 | Methods of preparing/optimizing perfume compositions | GIVAUDAN SA (CH) | 2025-06-24 | — | — | US | disclosed |
| EP-3429641-B1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2024-07-03 | — | — | EP | disclosed |
| EP-3310893-B2 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2024-02-28 | — | — | EP | disclosed |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-02-08 | — | — | US | disclosed |
| WO-2023072719-A1 | A FRAGRANCE COMPOSITION COMPRISING ALPHA-GUAIENE | GIVAUDAN SA (CH) | 2023-05-04 | — | — | WO | disclosed |
| US-20090325836-A1 | Cyclooct-(EN-)YL Derivatives for Use as Fragrances | GIVAUDAN SA (CH) | 2009-12-31 | — | — | US | disclosed |
| US-7605118-B2 | 1-cyclooct-3-enylpropan-1-one; -cyclooct-3-enylpropan-1-ol; perfume, household product, laundry product, body care product or cosmetic | GIVAUDAN SA (CH) | 2009-10-20 | — | — | US | disclosed |
| EP-1555998-B1 | CYCLOOCT-(EN-)YL DERIVATIVES FOR USE AS FRAGRANCES | GIVAUDAN SA (CH) | 2009-07-29 | — | — | EP | disclosed |
| US-20060014663-A1 | Cyclooct-(en-)yl derivatives for use as fragrances | GIVAUDAN SA (CH) | 2006-01-19 | — | — | US | disclosed |
| EP-1555998-A1 | CYCLOOCT-(EN-)YL DERIVATIVES FOR USE AS FRAGRANCES | Givaudan SA (CH) | 2005-07-27 | — | — | EP | disclosed |
| WO-2004035017-A1 | CYCLOOCT-(EN-)YL DERIVATIVES FOR USE AS FRAGRANCES | GIVAUDAN SA (CH) | 2004-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014663-A1 | Cyclooct-(en-)yl derivatives for use as fragrances | ENY2, FPR1, CNR1 | CES2 314/4885CES1 1101/4885ALDH1A1 379/4885 |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | AOX1, TYR, OCIAD1 | CES2 852/4885CES1 967/4885ALDH1A1 116/4885 |
| US-20090325836-A1 | Cyclooct-(EN-)YL Derivatives for Use as Fragrances | ENY2, FPR1, CNR1 | CES2 314/4885CES1 1101/4885ALDH1A1 379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.